Common risk factors for both arterial and venous thrombosis

British Journal of Haematology

Volumn 140, Issue 5, 2008, Pages 488-495

  Lowe, Gordon D O ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Myocardial infarction; Risk factors; Stroke; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ESTROGEN; HEPARIN; ORAL CONTRACEPTIVE AGENT;

ARTERY THROMBOSIS; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEG BLOOD FLOW; LOW DRUG DOSE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING HABIT; VENOUS THROMBOEMBOLISM;

ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; NEOPLASMS; RISK FACTORS; SMOKING; THROMBOSIS; VENOUS THROMBOSIS;

EID: 38949103390     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06973.x     Document Type: Review

References (77)

1. Ageno, W., Prandoni, P., Romauldi, E., Chirarduzzi, A., Dentali, F., Pesavento, R., Crowther, M. Venco, A. (2006) The metabolic syndrome and the risk of venous thrombosis: a case-control study. Journal of Thrombosis and Haemostasis, 4, 1914 1918.
2. Ageno, W., Becattini, C., Brighton, T., Selby, R. Kamphuisen, P.W. (2007) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Journal of Thrombosis and Haemostasis, 5 (Suppl. 2 O-W-059.
3. Agnelli, G. Becattini, C. (2006) Venous thromboembolism and atherosclerosis: common denominators or different diseases? Journal of Thrombosis and Haemostasis, 4, 1886 1890.
4. Albers, G.W., Amarenco, P., Easton, J.D., Sacco, R.L. Teal, P. (2004) Antithrombotic and thrombolytic therapy for ischemic stroke. Chest, 126, 483s 512s.
5. Antithrombotic Trialists' Collaboration 2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. British Medical Journal, 324, 71 86.
6. Becattini, C., Agnelli, G., Prandoni, P., Silingardi, M., Salvi, R., Taliani, M.R., Poggio, R., Imberti, D., Ageno, W., Pogliani, E., Porro, F. Casazza, F. (2005) A prospective study on cardiovascular events after acute pulmonary embolism. European Heart Journal, 26, 77 83.
7. Bloemenkamp, K.M.M. Helmerhorst, F.M. (2007) The oral contraceptive pill, mechanisms of vascular risk, and practical prescribing strategies for women with thrombotic problems. In : Women's Vascular Health (ed. by I.A. Greer, J. Ginsberg C.D. Forbes pp. 423 435. Arnold, London.
8. Blood Pressure Lowering Treatment Trialists' Collaborators 2003) Effects of different blood-pressure-lowering regimens on major cardiovascular events. Lancet, 362, 1527 1535.
9. Bova, C., Marchiori, A., Noto, A., Rossi, V., Daniele, F., Santoro, C., Ricchio, R., De Lorenzo, R., Umbaca, R. Prandoni, P. (2006) Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study. Thrombosis and Haemostasis, 96, 132 136.
10. Castaman, G., Tosetto, A., Simioni, M., Ruggeri, M., Madeo, D. Rodeghiero, F. (2001) Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis. Thrombosis and Haemostasis, 86, 804 808.
11. Cholesterol Trialists' Treatment Collaborators 2005) Efficacy and safety of cholesterol lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet, 366, 1269 1278.
12. Cuzick, J., Powles, T., Veronesi, U., Forbes, J., Edwards, R., Ashley, S. Boyle, P. (2003) Overview of the main outcomes in breast-cancer prevention trials. Lancet, 361, 296 300.
13. Doll, R., Peto, R., Boreham, J. Sutherland, I. (2004) Mortality in relation to smoking. British Medical Journal, 328, 1519 1528.
14. Eliasson, A., Bergqvist, D., Bjorck, M., Acosta, S., Sternby, N.H. Ogren, M. (2006) Prevalence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23,796 consecutive autopsies. Journal of Thrombosis and Haemostasis, 4, 1897 1902.
15. Emberson, J.R., Whincup, P.H., Morris, R.W., Walker, M., Lowe, G.D.O. Rumley, A. (2004) Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study. European Journal of Cardiovascular Prevention and Rehabilitation, 11, 125 134.
16. Fowkes, F.G.R., Lowe, G.D.O., Housley, E., Rattray, A., Rumley, A., Elton, R.A., MacGregor, I.R. Dawes, J. (1993) Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet, 342, 84 86.
17. Freeman, D.J., Robertson, M., Ford, I., Gaw, A., Greer, I.A., Stott, D.J. Lowe, G.D. (2007) Risk factors for the development of incident venous thrombotic events in the prospective study of pravastatin in the elderly at risk (PROSPER). Platelets, 18, Suppl. 1 18 (abstract).
18. Goldhaber, S.Z., Savage, D.D., Garrison, R.J., Castelli, W.P., Kannel, W.B., McNamara, P.M., Gherardi, G. Feinleib, M. (1983) Risk factors for pulmonary embolism. The Framingham study. American Journal of Medicine, 74, 1023 1028.
19. Goldhaber, S.Z., Grodstein, F., Stampfer, M.J., Manson, J.E., Colditz, G.A., Speizer, F.E., Willett, W.C. Hennekens, C.H. (1997) A prospective study of risk factors for pulmonary embolism in women. The Journal of the American Medical Association, 277, 642 645.
20. Gordon, T. Kannel, W.B. (1972) Predisposition to atherosclerosis in the head, heart and legs. The Framingham Study. The Journal of the American Medical Association, 221, 661.
21. Greaves, M., Cohen, H., Machin, S.J. Mackie, I., on behalf of the Haemostasis and Thrombosis Task Force of the British Committee for Standardisation in Haematology 2002) Guidelines on the investigation and management of the antiphospholipid syndrome. British Journal of Haematology, 109, 704 715.
22. Greer, I.A., Ginsberg, J. Forbes, C.D. (eds 2007) Women's Vascular Health. Arnold, London.
23. Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., Gordon, D.J., Krauss, R.M., Savage, P.J., Smith, S.C., Spertus, J.A. Costa, F. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112, 2735 2752.
24. van der Hagen, P.B., Folsom, A.R. Jenny, N.S. (2006) Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. Journal of Thrombosis and Haemostasis, 4, 1903 1908.
25. Hansson, P.O., Eriksson, H., Welin, L., Svardsudd, K. Wilhelmsen, L. (1999) Smoking and abdominal obestiy. Risk factors for VTE among middle-aged men. "The study of men born in 1913". Archives of Internal Medicine, 159, 1886 1890.
26. Heit, J.A. (2005) Venous thromboembolism: disease burden, outcomes and risk factors. Journal of Thrombosis and Haemostasis, 8, 1611 1617.
27. Heit, J.A., Silverstein, M.D., Mohr, D.N., Petterson, T.M., O'Fallon, W.M. Melton, III., L.J. (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Archives of Internal Medicine, 160, 809 815.
28. Hong, C., Zhu, F., Du, D., Pilgram, T.K., Sicard, G.A. Bae, K.T. (2005) Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. Atherosclerosis, 183, 169 174.
29. Hovens, M.M.C., Snoep, J.D., Tamsma, J.T. Huisman, M.V. (2006) Aspirin in the prevention and treatment of venous thromboembolism. Journal of Thrombosis and Haemostasis, 4, 1470 1475.
30. Hume, M., Sevitt, S. Thomas, D.P. (1970) Venous Thrombosis and Pulmonary Embolism. Harvard University Press, Cambridge, MA.
31. Joint British Societies 2005) JBS-2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society Stroke Association. Heart, 92 (Suppl. 5 1 52.
32. Juhan-Vague, I., Alessi, M.C. Orange, P.E. (2000) Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Annals of Medicine, 32, 78 84.
33. Kim, R.J. Becker, R.C. (2003) Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. American Heart Journal, 146, 948 957.
34. Kujovich, J.L. (2004) Hormones and pregnancy: thromboembolic risks for women. British Journal of Haematology, 126, 443 454.
35. Kyrle, P.A. Eichinger, S. (2005) Deep vein thrombosis. Lancet, 365, 1163 1174.
36. Levine, M.N., Lee, A.Y. Kakkar, A.K. (2003) From Trousseau to targeted therapy; new insights and innovations in thrombosis and cancer. Journal of Thrombosis and Haemostasis, 1, 1456 1463.
37. Libby, P., Ridker, P.M. Maseri, A. (2002) Inflammation and atherosclerosis. Circulation, 105, 1135 1143.
38. Lijfering, W.M., Ten Kate, M.K., Sprenger, H.G. van der Meer, J. (2006) Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy. Journal of Thrombosis and Haemostasis, 4, 1928 1930.
39. Lowe, G.D.O. (2006a) Arterial disease and venous thrombosis: are they related, and if so, what should we do about it? Journal of Thrombosis and Haemostasis, 4, 1882 1885.
40. Lowe, G.D.O. (2006b) Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. British Journal of Haematology, 133, 232 250.
41. Lowe, G.D.O. (2007) Update on the cardiovascular risks of hormone replacement therapy. Women's Health, 3, 87 97.
42. Lowe, G.D.O., Rumley, A., Woodward, M., Morrison, C.E., Philippou, H., Lane, D.A. Tunstall-Pedoe, H. (1997) Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. British Journal of Haematology, 97, 775 784.
43. Medical Research Council's General Practice Framework 1998) Thrombosis prevention trial. Lancet, 351, 233 241.
44. Nieto, F.J. (1999) Cardiovascular disease and risk factor epidemiology: a look back at the epidemic of the 20th century. American Journal of Public Health, 89, 292 294.
45. Pomp, E.R., Rosendaal, F.R. Doggen, C.J.M. (2007) Smoking Increases the Risk of Venous Thrombosis. 2007 International Society on Thrombosis and Haemostasis Abstracts (P-T-546). XXIst Congress of the International Society on Thrombosis and Haemostasis. Available at http://isth2007.abstractsondemand.com/ [Accessed 31 December 2007].
46. Prandoni, P., Bilora, F., Marchiori, A., Bernardi, E., Petrobelli, F., Lensing, A.W., Prins, M.H. Girolami, A. (2003) An association between atherosclerosis and venous thrombosis. New England Journal of Medicine, 348, 1435 1441.
47. Prandoni, P., Ghirarduzzi, A., Prins, M.H., Pengo, V., Davidson, B.L., Sorensen, H.T., Pesavento, R., Iotti, M., Casiglia, E., Ileceto, S., Pagnana, A. Lensing, A.W. (2006) Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. Journal of Thrombosis and Haemostasis, 4, 1891 1896.
48. Prandoni, P., Villalta, S., Tormene, D., Spiezia, L. Pesavento, R. (2007) Immobilisation resulting from chronic medical diseases: a new risk factor for recurrent venous thromboembolism in anticoagulated patients. Journal of Thrombosis and Haemostasis, 5, 1786 1787.
49. Ray, J.G. (2003) Dyslipidemia, statins and venous thromboembolism: a potential risk factor and a potential treatment. Current Opinion in Pulmonary Medicine, 9, 378 384.
50. Reich, L., Folsom, A.R., Key, N.S., Boland, L.L., Heckbert, S.R., Rosamond, W.D. Cushman, M. (2006) Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism. Journal of Thrombosis and Haemostasis, 4, 1909 1913.
51. Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G.D., Walker, I.D., Greaves, M., Brenkel, I., Regan, L. Greer, I.A., The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study 2006) Thrombophilia in pregnancy: a systematic review. British Journal of Haematology, 132, 171 196.
52. Rosendaal, F.R. (1999) Venous thrombosis: a multicausal disease. Lancet, 353, 1167 1173.
53. Rosendaal, F.R., van Hylckama Vlieg, A., Tanis, B.C. Helmerhorst, M. (2003) Estrogens, progestogens and thrombosis. Journal of Thrombosis and Haemostasis, 1, 1371 1380.
54. Ross, R. (1999) Atherosclerosis - an inflammatory disease. New England Journal of Medicine, 340, 115 126.
55. Rumley, A., Emberson, J.R., Wannamethee, S.G., Lennon, L., Whincup, P.H. Lowe, G.D. (2006) Effects of older age on fibrin D-dimer, C-reactive protein and other hemostatic and inflammatory variables in men aged 60-79 years. Journal of Thrombosis and Haemostasis, 4, 982 987.
56. Schulman, S., Lindmarker, P., Holmstrom, M., Larfars, G., Carlsson, A., Nicol, P., Svensson, E., Ljungberg, B., Viering, S., Nordlander, S., Leijd, B., Jahed, K., Hjorth, M., Linder, O. Beckman, M. (2006) Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. Journal of Thrombosis and Haemostasis, 4, 734 742.
57. Scottish Intercollegiate Guidelines' Network (SIGN) 2007a) Stable Angina. SIGN, Edinburgh (http://www.sign.ac.uk/pdf/sign96.pdf). [Accessed 31 December 2007].
58. Scottish Intercollegiate Guidelines Network (SIGN) 2007b) Risk Estimation and the Prevention of Cardiovascular Disease. SIGN, Edinburgh (http://www.sign.ac.uk/pdf/sign97.pdf). [Accessed 31 December 2007].
59. Smeeth, L., Thomas, S.L., Hall, A.J., Hubbard, R., Farrington, P. Vallance, P. (2004) Risk of myocardial infarction and stroke after acute infection or vaccination. New England Journal of Medicine, 351, 2611 2618.
60. Smeeth, L., Cook, C., Thomas, S., Hall, A.J., Hubbard, R. Vallance, P. (2006) Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet, 367, 1075 1079.
61. Smith, A., Patterson, C., Yarnell, J., Rumley, A., Ben-Shlomo, Y. Lowe, G. (2005) Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation, 112, 3080 3087.
62. Sorensen, H.T., Horvath-Puho, E., Pedersen, L., Baron, J.A. Prandoni, P. (2007) Venous thromboembolism and subsequent hospitalization due to acute arterial cardiovascular events - a 20 year cohort study. Lancet, 370, 1773 1779.
63. Squizzato, A., Romualdi, E. Ageno, W. (2006) Why should statins prevent venous thromboembolism? A systematic literature search and a call for action. Journal of Thrombosis and Haemostasis, 4, 1925 1927.
64. Tsai, A., Cushman, M., Rosamond, W., Heckbert, S., Polak, J.F. Folsom, A.R. (2002) Cardiovascular risk factors and VTE incidence. Archives of Internal Medicine, 162, 1182 1189.
65. Tzoulaki, I., Murray, G.D., Price, J.F., Smith, F.B., Lee, A.J., Rumley, A., Lowe, G.D. Fowkes, F.G. (2006) Hemostatic factors, inflammatory markers and progressive peripheral atherosclerosis: the Edinburgh Artery Study. American Journal of Epidemiology, 163, 334 341.
66. Wannamethee, S.G., Lowe, G.D.O., Whincup, P.H., Rumley, A., Walker, M. Lennon, L. (2002) Physical activity and hemostatic and inflammatory variables in elderly men. Circulation, 105, 1785 1790.
67. Wannamethee, S.G., Lowe, G.D.O., Shaper, A.G., Rumley, A., Lennon, L. Whincup, P.H. (2004) Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in type 2 diabetes with and without coronary heart disease. Diabetologia, 47, 1557 1565.
68. Wannamethee, S.G., Lowe, G.D.O., Shaper, A.G., Rumley, A., Lennon, L. Whincup, P.H. (2005a) The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. Atherosclerosis, 181, 101 108.
69. Wannamethee, S.G., Lowe, G.D.O., Shaper, A.G., Rumley, A., Lennon, L. Whincup, P.H. (2005b) Association between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. European Heart Journal, 26, 1765 1773.
70. Woodward, M., Lowe, G.D.O., Rumley, A., Tunstall-Pedoe, H., Philippou, H., Lane, D.A. Morrison, C.E. (1997) Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. British Journal of Haematology, 97, 785 797.
71. World Health Organisation 2004) Improving Access to Quality Care in Family Planning. Medical Eligibility Criteria for Contraceptive Use, 3rd edn. WHO, Geneva.
72. Wu, O., Clark, P., Lowe, G.D.O., Walker, I.D. Greer, I.A. (2005a) Thrombophilia and venous thromboembolism after total hip or knee replacement surgery: a systematic review. Journal of Thrombosis and Haemostasis, 2005, 3.
73. Wu, O., Robertson, L., Langhorne, P., Twaddle, S., Lowe, G.D.O., Clark, P., Greaves, M., Walker, I.D., Brenkel, I., Regan, L. Greer, I.A. (2005b) Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. Thrombosis and Haemostasis, 94, 17 25.
74. Wu, O., Robertson, L., Twaddle, S., Lowe, G., Clark, P., Walker, I., Brenkel, I., Greaves, M., Langhorne, P., Regan, L. Greer, I. (2005c) Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. British Journal of Haematology, 131, 80 90.
75. Wu, O., Robertson, L., Twaddle, S., Lowe, G.D., Clark, P., Greaves, M., Walker, I.D., Langhorne, P., Brenkel, I., Regan, L. Greer, I. (2006) Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessement of Thrombophilia Screening (TREATS) study. Health Technology Assessment (Winchester, England), 10, 1 110.
76. Ye, Z., Liu, E.H.C., Higgins, J.P.T., Keavney, B.D., Lowe, G.D.O., Collins, R. Danesh, J. (2006) Seven haemostatic polymorphisms and coronary disease: a meta analysis comprising 66155 cases and 91307 controls. Lancet, 367, 651 658.
77. Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J. Lisheng, L., on behalf of the INTERHEART Study Investigators 2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): case-control study. Lancet, 364, 937 952.